This Article Free upon publication Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sacco, R. L. Articles by Tomsick, T. Search for Related Content PubMed PubMed Citation Articles by Sacco, R. L. Articles by Tomsick, T. Pubmed/NCBI databases Medline Plus Health Information Stroke Transient Ischemic Attack Related Collections AHA Statements and Guidelines Acute Stroke Syndromes Primary and Secondary Stroke Prevention Transient Ischemic Attacks Related Internet Resources

(Circulation. 2006;113:e409-e449.)
© 2006 American Heart Association, Inc.

AHA/ASA Guideline

Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack

A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.

Ralph L. Sacco, MD, MS, FAHA, FAAN, Chair; Robert Adams, MD, FAHA, Vice Chair; Greg Albers, MD; Mark J. Alberts, MD, FAHA; Oscar Benavente, MD; Karen Furie, MD, MPH, FAHA; Larry B. Goldstein, MD, FAHA, FAAN; Philip Gorelick, MD, MPH, FAHA, FAAN; Jonathan Halperin, MD, FAHA; Robert Harbaugh, MD, FACS, FAHA; S. Claiborne Johnston, MD, PhD; Irene Katzan, MD, FAHA; Margaret Kelly-Hayes, RN, EdD, FAHA; Edgar J. Kenton, MD, FAHA, FAAN; Michael Marks, MD; Lee H. Schwamm, MD, FAHA; Thomas Tomsick, MD, FAHA

The aim of this new statement is to provide comprehensive and timely evidence-based recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or transient ischemic attack. Evidence-based recommendations are included for the control of risk factors, interventional approaches for atherosclerotic disease, antithrombotic treatments for cardioembolism, and the use of antiplatelet agents for noncardioembolic stroke. Further recommendations are provided for the prevention of recurrent stroke in a variety of other specific circumstances, including arterial dissections; patent foramen ovale; hyperhomocysteinemia; hypercoagulable states; sickle cell disease; cerebral venous sinus thrombosis; stroke among women, particularly with regard to pregnancy and the use of postmenopausal hormones; the use of anticoagulation after cerebral hemorrhage; and special approaches for the implementation of guidelines and their use in high-risk populations.

Key Words: AHA Scientific Statements • ischemia • ischemia attack, transient • stroke

Related Internet Resources:

Slide Set by the Stroke Council Professional Education Committee

This article has been cited by other articles:

				M. A. Martinez-Garcia, J. J. Soler-Cataluna, L. Ejarque-Martinez, Y. Soriano, P. Roman-Sanchez, F. B. Illa, J. M. M. Canal, and J. Duran-Cantolla Continuous Positive Airway Pressure Treatment Reduces Mortality in Patients with Ischemic Stroke and Obstructive Sleep Apnea: A 5-Year Follow-up Study Am. J. Respir. Crit. Care Med., July 1, 2009; 180(1): 36 - 41. [Abstract] [Full Text] [PDF]

				D. Kleindorfer, J. Khoury, J. P. Broderick, E. Rademacher, D. Woo, M. L. Flaherty, K. Alwell, C. J. Moomaw, A. Schneider, A. Pancioli, et al. Temporal Trends in Public Awareness of Stroke: Warning Signs, Risk Factors, and Treatment Stroke, July 1, 2009; 40(7): 2502 - 2506. [Abstract] [Full Text] [PDF]

				P. T. O'Gara, S. R. Messe, E. M. Tuzcu, G. Catha, and J. C. Ring Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention: A Call for Completion of Randomized Clinical Trials A Science Advisory From the American Heart Association/American Stroke Association and the American College of Cardiology Foundation The American Academy of Neurology affirms the value of this science advisory J. Am. Coll. Cardiol., May 26, 2009; 53(21): 2014 - 2018. [Abstract] [Full Text] [PDF]

				P. T. O'Gara, S. R. Messe, E. M. Tuzcu, G. Catha, and J. C. Ring Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention: A Call for Completion of Randomized Clinical Trials: A Science Advisory From the American Heart Association/American Stroke Association and the American College of Cardiology Foundation The American Academy of Neurology affirms the value of this science advisory. Circulation, May 26, 2009; 119(20): 2743 - 2747. [Abstract] [Full Text] [PDF]

				M. R. Di Tullio, C. Russo, Z. Jin, R. L. Sacco, J.P. Mohr, S. Homma, and for the Patent Foramen Ovale in Cryptogenic Stroke Aortic Arch Plaques and Risk of Recurrent Stroke and Death Circulation, May 5, 2009; 119(17): 2376 - 2382. [Abstract] [Full Text] [PDF]

				T. Kurth and M.-G. Bousser Stroke in Women: An Evolving Topic Stroke, April 1, 2009; 40(4): 1027 - 1028. [Full Text] [PDF]

				G. Saposnik, S. G. Goodman, L. A. Leiter, R. T. Yan, D. H. Fitchett, N. H. Bayer, A. Casanova, A. Langer, A. T. Yan, for the Vascular Protection (VP), et al. Applying the Evidence: Do Patients With Stroke, Coronary Artery Disease, or Both Achieve Similar Treatment Goals? Stroke, April 1, 2009; 40(4): 1417 - 1424. [Abstract] [Full Text] [PDF]

				M. Cohen Expanding the Recognition and Assessment of Bleeding Events Associated With Antiplatelet Therapy in Primary Care Mayo Clin. Proc., February 1, 2009; 84(2): 149 - 160. [Abstract] [Full Text] [PDF]

				S. R. Messe and S. E. Kasner Patent Foramen Ovale in Cryptogenic Stroke: Not to Close Circulation, November 4, 2008; 118(19): 1999 - 2004. [Full Text] [PDF]

				M. R. Di Tullio, S. Homma, Z. Jin, and R. L. Sacco Aortic Atherosclerosis, Hypercoagulability, and Stroke: The APRIS (Aortic Plaque and Risk of Ischemic Stroke) Study J. Am. Coll. Cardiol., September 2, 2008; 52(10): 855 - 861. [Abstract] [Full Text] [PDF]

				A. Cohen Atherosclerosis of the Thoracic Aorta: Further Characterization for Higher Risk of Vascular Events J. Am. Coll. Cardiol., September 2, 2008; 52(10): 862 - 864. [Full Text] [PDF]

				D. Sander, K. Sander, and H. Poppert Review: Stroke in type 2 diabetes The British Journal of Diabetes & Vascular Disease, September 1, 2008; 8(5): 222 - 229. [Abstract] [PDF]

				J. J. Ricotta II and R. D. Malgor A Review of the Trials Comparing Carotid Endarterectomy and Carotid Angioplasty and Stenting Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2008; 20(3): 299 - 308. [Abstract] [PDF]

				A. I. Qureshi Acute Hypertensive Response in Patients With Stroke: Pathophysiology and Management Circulation, July 8, 2008; 118(2): 176 - 187. [Full Text] [PDF]

				M. Rodriguez-Yanez, J. Agulla, R. Rodriguez-Gonzalez, T. Sobrino, and J. Castillo Review: Statins and stroke Therapeutic Advances in Cardiovascular Disease, June 1, 2008; 2(3): 157 - 166. [Abstract] [PDF]

				C L Shovlin, J E Jackson, K B Bamford, I H Jenkins, A R Benjamin, H Ramadan, and E Kulinskaya Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia Thorax, March 1, 2008; 63(3): 259 - 266. [Abstract] [Full Text] [PDF]

				C. M. Wu, K. McLaughlin, D. L. Lorenzetti, M. D. Hill, B. J. Manns, and W. A. Ghali Early Risk of Stroke After Transient Ischemic Attack: A Systematic Review and Meta-analysis Arch Intern Med, December 10, 2007; 167(22): 2417 - 2422. [Abstract] [Full Text] [PDF]

				N. A. Nickman, J. Biskupiak, F. Creekmore, H. Shah, and D. I . Brixner Antiplatelet medication management in patients hospitalized with ischemic stroke Am. J. Health Syst. Pharm., November 1, 2007; 64(21): 2250 - 2256. [Abstract] [Full Text] [PDF]

				E. R Mohler III Carotid stenting for atherothrombosis Heart, September 1, 2007; 93(9): 1147 - 1151. [Full Text] [PDF]

				R. Zahn, M. Hochadel, U. Zeymer, J. Senges, and H. Mudra Concerns on carotid stenting in octogenarians: reply Eur. Heart J., August 2, 2007; 28(16): 2045 - 2045. [Full Text] [PDF]

				J. Hirsh, M. O'Donnell, and J. W. Eikelboom Beyond Unfractionated Heparin and Warfarin: Current and Future Advances Circulation, July 31, 2007; 116(5): 552 - 560. [Full Text] [PDF]

				J. F. Meschia, T. G. Brott, and R. W. Hobson II Diagnosis and Invasive Management of Carotid Atherosclerotic Stenosis Mayo Clin. Proc., July 1, 2007; 82(7): 851 - 858. [Abstract] [Full Text] [PDF]

				O. I.I. Soliman, M. L. Geleijnse, F. J. Meijboom, A. Nemes, O. Kamp, P. Nihoyannopoulos, N. Masani, S. B. Feinstein, and F. J. Ten Cate The use of contrast echocardiography for the detection of cardiac shunts Eur J Echocardiogr, June 1, 2007; 8(3): s2 - s12. [Abstract] [Full Text] [PDF]

				A. I. Qureshi Carotid Angioplasty and Stent Placement after EVA-3S Trial Stroke, June 1, 2007; 38(6): 1993 - 1996. [Full Text] [PDF]

				I. Inglessis and M. J. Landzberg Interventional Catheterization in Adult Congenital Heart Disease Circulation, March 27, 2007; 115(12): 1622 - 1633. [Full Text] [PDF]

				Ph. G. Steg, D. L. Bhatt, P. W. F. Wilson, R. D'Agostino Sr, E. M. Ohman, J. Rother, C.-S. Liau, A. T. Hirsch, J.-L. Mas, Y. Ikeda, et al. One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis JAMA, March 21, 2007; 297(11): 1197 - 1206. [Abstract] [Full Text] [PDF]

				V. J. Howard, L. A. McClure, J. F. Meschia, L. Pulley, S. C. Orr, and G. H. Friday High Prevalence of Stroke Symptoms Among Persons Without a Diagnosis of Stroke or Transient Ischemic Attack in a General Population: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. Arch Intern Med, October 9, 2006; 166(18): 1952 - 1958. [Abstract] [Full Text] [PDF]

				August 22 Highlight and Commentary: Predictors of recurrent stroke in African Americans Neurology, August 22, 2006; 67(4): 553 - 553. [Full Text] [PDF]